Fractyl Health, Inc., a metabolic therapeutics company, is dedicated to developing new treatments for diseases like obesity and type 2 diabetes (T2D). Despite advancements in treatment, these diseases continue to pose significant health risks. The company’s mission is to shift the focus of metabolic disease treatment from managing symptoms to providing long-lasting therapies that target the root causes of the diseases.
Fractyl Health is headquartered in Burlington, MA. For more information about the company, visit their website or follow them on Twitter. To register for the webcast of Dr. Harith Rajagopalan’s fireside chat at the upcoming BofA Securities 2024 Health Care Conference on May 15, 2024, at 4:20 p.m. PDT (7:20 p.m. EDT), visit the company’s website.
For corporate inquiries, contact Lisa Davidson, Chief Financial Officer at ir@fractyl.com or 781.902.8800. For media inquiries, reach out to Beth Brett, Corporate Communications at bbrett@fractyl.com or 720.656.6544